IVDs star in German rare diseases plan, but will commercial benefits match?
This article was originally published in Clinica
Executive Summary
After almost three years of interministerial collaboration, Germany’s national action plan for sufferers of rare diseases, NAMSE, has been published and released to the German cabinet.